Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
335.66
+4.37 (+1.32%)
Streaming Delayed Price
Updated: 1:06 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
43
44
Next >
10 Best Dividend Growth Stocks to Buy and Hold Forever
July 21, 2024
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Via
The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
Q2 Earnings Season Scorecard, Economic Outlook And Analyst Reports For Nvidia, Meta & Others
July 18, 2024
Today's Research Daily features a real-time update on the Q2 earnings season, the July Economic Outlook monthly, and new research reports on 16 major stocks, including NVIDIA, Meta, and Amgen as well...
Via
Talk Markets
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.
Via
Benzinga
Unpacking the Latest Options Trading Trends in Amgen
July 16, 2024
Via
Benzinga
A Closer Look at Amgen's Options Market Dynamics
July 15, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Roche released early-stage data on its oral weight-loss drug.
Via
Investor's Business Daily
7 Dividend Stocks That Just Raised Their Payouts: July 2024
July 17, 2024
Dividend stocks have a long history of outperforming non-dividend-paying stocks, but those that increase their payout do even better.
Via
InvestorPlace
Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
July 16, 2024
Biogen has $8 billion to $10 billion in dry powder for acquisitions. Here are three names the company could examine.
Via
Investor's Business Daily
3 Quantum AI Stocks That Could Redefine Computing
July 16, 2024
Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Biotech Stocks to Buy Now: Q3 Edition
July 15, 2024
Biotech stocks to buy can be a strong portfolio addition due to their capability for rapid growth within an evolving industry.
Via
InvestorPlace
Check Out What Whales Are Doing With AMGN
July 11, 2024
Via
Benzinga
CPI Data Sparks Rally in Biotech Stocks
July 15, 2024
Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
What Is the Dividend Payout for Amgen Stock?
July 15, 2024
Amgen offers a packed pipeline and healthy dividend distributions.
Via
The Motley Fool
Positive News is Driving This Cancer Drug Maker’s Stock Higher
July 15, 2024
IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather
Via
MarketBeat
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Revenue is climbing at these two drug companies -- and the trend should continue.
Via
The Motley Fool
3 Dividend Growth Stocks to Buy and Hold
July 14, 2024
What's better than a dividend? A dividend that's growing.
Via
The Motley Fool
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
July 12, 2024
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
TSLA Hit Our Target - Here’s What’s Next
July 09, 2024
We’ll look at another big mover right now: precious metals. They still look good after Fed Chair Jerome Powell tried to talk down rate cuts today.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
Via
InvestorPlace
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
This pharma company is posting double-digit revenue growth.
Via
The Motley Fool
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Discover three top high-growth small-cap stocks, fueled by potential rate cuts and promising prospects in the second half of 2024.
Via
InvestorPlace
3 Dividend Stocks Crushing the S&P 500 With 30%+ Annual Total Returns
July 08, 2024
With technology growth stocks propelling the S&P 500, dividend stocks have often found themselves playing catch-up. But not these three.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs.
Via
Benzinga
Topics
ETFs
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
July 06, 2024
Samsung Biologics, a Korean CDMO, signed a $1.06 billion agreement to provide manufacturing services for an unnamed US pharma. The agreement is the largest that Samsung Bio has made since it was...
Via
Talk Markets
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
Amgen, Inc. Dividend Stock Analysis
July 05, 2024
Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
Via
Talk Markets
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.